Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model

Application of Photobiomodulation therapy (PBMT) and meloxicam in acute spinal cord injury, functional recovery and histological evaluation. Evaluation of the effect of simultaneous PBMT and meloxicam on treatment of acute experimental spinal cord injury and comparing it with the effect of applicati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of photochemistry and photobiology. B, Biology Biology, 2018-12, Vol.189, p.49-54
Hauptverfasser: Pedram, Mir Sepehr, Dehghan, Mohammad Mehdi, Shojaee, Maryam, Fekrazad, Reza, Sharifi, Davood, Farzan, Arash, Ghasemi, Setareh, AliMohammad Kalhori, Katayoun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 54
container_issue
container_start_page 49
container_title Journal of photochemistry and photobiology. B, Biology
container_volume 189
creator Pedram, Mir Sepehr
Dehghan, Mohammad Mehdi
Shojaee, Maryam
Fekrazad, Reza
Sharifi, Davood
Farzan, Arash
Ghasemi, Setareh
AliMohammad Kalhori, Katayoun
description Application of Photobiomodulation therapy (PBMT) and meloxicam in acute spinal cord injury, functional recovery and histological evaluation. Evaluation of the effect of simultaneous PBMT and meloxicam on treatment of acute experimental spinal cord injury and comparing it with the effect of application of each of them separately. The study was conducted at the Department of Surgery & Radiology, Faculty of Veterinary Medicine and Institute of Biomedical Research, University of Tehran, Tehran, Iran. Twenty four rats were used in this study. A compression injury was induced to the T8-T9 segment of the spinal cord of rats using a Fogarty embolectomy catheter. Rats were randomly divided into 4 groups including: Control group, PBMT (810 nm-200 mw-8 s-2 weeks) group, Meloxicam (1 mg/kg) group, and PBMT and Meloxicam (mixed) group. After inducing injury, hind limb performance of the rats was evaluated, using BBB test and then treatment intervention was performed and continued for 2 weeks. Four  weeks after injury induction, BBB test results were significantly higher in all treatment groups in comparison to control group, however, there were no significant differences among the treatment groups. In addition, histological findings revealed no significant difference between all 4 study groups. According to the results of this study we can conclude that simultaneous and separate application of PBMT and Meloxicam play an effective role in treatment of acute spinal cord injuries. •Administration of meloxicam can improve clinical features after spinal cord injury.•Using PBMT can improve functional activity of rats suffered from SCI.•Simultaneous application of PBMT and Meloxicam play effective role in treatment of SCI
doi_str_mv 10.1016/j.jphotobiol.2018.09.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2119930015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1011134418305712</els_id><sourcerecordid>2119930015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-75663c25b067c76e146476287826a7b20ff6c499d7a6f442f2f60326c9e5452a3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS1ERX_gFZAlNmWRYDuOnbCjFRSkVq3QsLY8zrXqKImD7VSdh-Fd8TQDSGxqWfKPvnOP7j0IYUpKSqj40Jf9fO-T3zo_lIzQpiRtSRh7gU5oI6uCiYa9zHdCaUErzo_RaYw9yasW8hU6rkhFWcvICfq1uYegZ1iSMxisBZMi9hZHNy5D0hP4JeK7g9fou2XQyfkJpyfZDp_fXdxs3mM9dfgGBv_ojB6x7kY3uZjCyuYNjzMEN8KU9IC1WRLgOLspP4wPHXZTv4TdR_xdp1zKjfk_e8HwGh1ZPUR4czjP0I8vnzeXX4vr26tvl5-uC8MJS4WshagMq7dESCMFUC64FKyRDRNabhmxVhjetp3UwnLOLLOCVEyYFmpeM12dofO17hz8zwViUqOLBoZhHYBilLZtRQitM_ruP7T3S8id7CmRq9WkbTLVrJQJPsYAVs25fR12ihK1j1D16l-Eah-hIq3KEWbp24PBsh2h-yv8k1kGLlYA8kQeHAQVjYPJQOdCjk913j3v8ht9H7QZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2164525098</pqid></control><display><type>article</type><title>Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Pedram, Mir Sepehr ; Dehghan, Mohammad Mehdi ; Shojaee, Maryam ; Fekrazad, Reza ; Sharifi, Davood ; Farzan, Arash ; Ghasemi, Setareh ; AliMohammad Kalhori, Katayoun</creator><creatorcontrib>Pedram, Mir Sepehr ; Dehghan, Mohammad Mehdi ; Shojaee, Maryam ; Fekrazad, Reza ; Sharifi, Davood ; Farzan, Arash ; Ghasemi, Setareh ; AliMohammad Kalhori, Katayoun</creatorcontrib><description>Application of Photobiomodulation therapy (PBMT) and meloxicam in acute spinal cord injury, functional recovery and histological evaluation. Evaluation of the effect of simultaneous PBMT and meloxicam on treatment of acute experimental spinal cord injury and comparing it with the effect of application of each of them separately. The study was conducted at the Department of Surgery &amp; Radiology, Faculty of Veterinary Medicine and Institute of Biomedical Research, University of Tehran, Tehran, Iran. Twenty four rats were used in this study. A compression injury was induced to the T8-T9 segment of the spinal cord of rats using a Fogarty embolectomy catheter. Rats were randomly divided into 4 groups including: Control group, PBMT (810 nm-200 mw-8 s-2 weeks) group, Meloxicam (1 mg/kg) group, and PBMT and Meloxicam (mixed) group. After inducing injury, hind limb performance of the rats was evaluated, using BBB test and then treatment intervention was performed and continued for 2 weeks. Four  weeks after injury induction, BBB test results were significantly higher in all treatment groups in comparison to control group, however, there were no significant differences among the treatment groups. In addition, histological findings revealed no significant difference between all 4 study groups. According to the results of this study we can conclude that simultaneous and separate application of PBMT and Meloxicam play an effective role in treatment of acute spinal cord injuries. •Administration of meloxicam can improve clinical features after spinal cord injury.•Using PBMT can improve functional activity of rats suffered from SCI.•Simultaneous application of PBMT and Meloxicam play effective role in treatment of SCI</description><identifier>ISSN: 1011-1344</identifier><identifier>EISSN: 1873-2682</identifier><identifier>DOI: 10.1016/j.jphotobiol.2018.09.022</identifier><identifier>PMID: 30312920</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Animals ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; BBB test ; Combined Modality Therapy - methods ; Compression ; Effects ; Evaluation ; Experiments ; Injuries ; Light therapy ; Low-Level Light Therapy - methods ; Medical instruments ; Meloxicam ; Meloxicam - therapeutic use ; NSAIDs ; Photobiomodulation therapy (PBMT) ; Radiology ; Rats ; Recovery of function ; Rodents ; Spinal cord injuries ; Spinal Cord Injuries - therapy ; Spinal cord injury ; Surgery ; Therapy ; Treatment Outcome ; Veterinary ; Veterinary medicine</subject><ispartof>Journal of photochemistry and photobiology. B, Biology, 2018-12, Vol.189, p.49-54</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Dec 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-75663c25b067c76e146476287826a7b20ff6c499d7a6f442f2f60326c9e5452a3</citedby><cites>FETCH-LOGICAL-c402t-75663c25b067c76e146476287826a7b20ff6c499d7a6f442f2f60326c9e5452a3</cites><orcidid>0000-0002-8825-9070</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1011134418305712$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30312920$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pedram, Mir Sepehr</creatorcontrib><creatorcontrib>Dehghan, Mohammad Mehdi</creatorcontrib><creatorcontrib>Shojaee, Maryam</creatorcontrib><creatorcontrib>Fekrazad, Reza</creatorcontrib><creatorcontrib>Sharifi, Davood</creatorcontrib><creatorcontrib>Farzan, Arash</creatorcontrib><creatorcontrib>Ghasemi, Setareh</creatorcontrib><creatorcontrib>AliMohammad Kalhori, Katayoun</creatorcontrib><title>Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model</title><title>Journal of photochemistry and photobiology. B, Biology</title><addtitle>J Photochem Photobiol B</addtitle><description>Application of Photobiomodulation therapy (PBMT) and meloxicam in acute spinal cord injury, functional recovery and histological evaluation. Evaluation of the effect of simultaneous PBMT and meloxicam on treatment of acute experimental spinal cord injury and comparing it with the effect of application of each of them separately. The study was conducted at the Department of Surgery &amp; Radiology, Faculty of Veterinary Medicine and Institute of Biomedical Research, University of Tehran, Tehran, Iran. Twenty four rats were used in this study. A compression injury was induced to the T8-T9 segment of the spinal cord of rats using a Fogarty embolectomy catheter. Rats were randomly divided into 4 groups including: Control group, PBMT (810 nm-200 mw-8 s-2 weeks) group, Meloxicam (1 mg/kg) group, and PBMT and Meloxicam (mixed) group. After inducing injury, hind limb performance of the rats was evaluated, using BBB test and then treatment intervention was performed and continued for 2 weeks. Four  weeks after injury induction, BBB test results were significantly higher in all treatment groups in comparison to control group, however, there were no significant differences among the treatment groups. In addition, histological findings revealed no significant difference between all 4 study groups. According to the results of this study we can conclude that simultaneous and separate application of PBMT and Meloxicam play an effective role in treatment of acute spinal cord injuries. •Administration of meloxicam can improve clinical features after spinal cord injury.•Using PBMT can improve functional activity of rats suffered from SCI.•Simultaneous application of PBMT and Meloxicam play effective role in treatment of SCI</description><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>BBB test</subject><subject>Combined Modality Therapy - methods</subject><subject>Compression</subject><subject>Effects</subject><subject>Evaluation</subject><subject>Experiments</subject><subject>Injuries</subject><subject>Light therapy</subject><subject>Low-Level Light Therapy - methods</subject><subject>Medical instruments</subject><subject>Meloxicam</subject><subject>Meloxicam - therapeutic use</subject><subject>NSAIDs</subject><subject>Photobiomodulation therapy (PBMT)</subject><subject>Radiology</subject><subject>Rats</subject><subject>Recovery of function</subject><subject>Rodents</subject><subject>Spinal cord injuries</subject><subject>Spinal Cord Injuries - therapy</subject><subject>Spinal cord injury</subject><subject>Surgery</subject><subject>Therapy</subject><subject>Treatment Outcome</subject><subject>Veterinary</subject><subject>Veterinary medicine</subject><issn>1011-1344</issn><issn>1873-2682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS1ERX_gFZAlNmWRYDuOnbCjFRSkVq3QsLY8zrXqKImD7VSdh-Fd8TQDSGxqWfKPvnOP7j0IYUpKSqj40Jf9fO-T3zo_lIzQpiRtSRh7gU5oI6uCiYa9zHdCaUErzo_RaYw9yasW8hU6rkhFWcvICfq1uYegZ1iSMxisBZMi9hZHNy5D0hP4JeK7g9fou2XQyfkJpyfZDp_fXdxs3mM9dfgGBv_ojB6x7kY3uZjCyuYNjzMEN8KU9IC1WRLgOLspP4wPHXZTv4TdR_xdp1zKjfk_e8HwGh1ZPUR4czjP0I8vnzeXX4vr26tvl5-uC8MJS4WshagMq7dESCMFUC64FKyRDRNabhmxVhjetp3UwnLOLLOCVEyYFmpeM12dofO17hz8zwViUqOLBoZhHYBilLZtRQitM_ruP7T3S8id7CmRq9WkbTLVrJQJPsYAVs25fR12ihK1j1D16l-Eah-hIq3KEWbp24PBsh2h-yv8k1kGLlYA8kQeHAQVjYPJQOdCjk913j3v8ht9H7QZ</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Pedram, Mir Sepehr</creator><creator>Dehghan, Mohammad Mehdi</creator><creator>Shojaee, Maryam</creator><creator>Fekrazad, Reza</creator><creator>Sharifi, Davood</creator><creator>Farzan, Arash</creator><creator>Ghasemi, Setareh</creator><creator>AliMohammad Kalhori, Katayoun</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8825-9070</orcidid></search><sort><creationdate>201812</creationdate><title>Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model</title><author>Pedram, Mir Sepehr ; Dehghan, Mohammad Mehdi ; Shojaee, Maryam ; Fekrazad, Reza ; Sharifi, Davood ; Farzan, Arash ; Ghasemi, Setareh ; AliMohammad Kalhori, Katayoun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-75663c25b067c76e146476287826a7b20ff6c499d7a6f442f2f60326c9e5452a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>BBB test</topic><topic>Combined Modality Therapy - methods</topic><topic>Compression</topic><topic>Effects</topic><topic>Evaluation</topic><topic>Experiments</topic><topic>Injuries</topic><topic>Light therapy</topic><topic>Low-Level Light Therapy - methods</topic><topic>Medical instruments</topic><topic>Meloxicam</topic><topic>Meloxicam - therapeutic use</topic><topic>NSAIDs</topic><topic>Photobiomodulation therapy (PBMT)</topic><topic>Radiology</topic><topic>Rats</topic><topic>Recovery of function</topic><topic>Rodents</topic><topic>Spinal cord injuries</topic><topic>Spinal Cord Injuries - therapy</topic><topic>Spinal cord injury</topic><topic>Surgery</topic><topic>Therapy</topic><topic>Treatment Outcome</topic><topic>Veterinary</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pedram, Mir Sepehr</creatorcontrib><creatorcontrib>Dehghan, Mohammad Mehdi</creatorcontrib><creatorcontrib>Shojaee, Maryam</creatorcontrib><creatorcontrib>Fekrazad, Reza</creatorcontrib><creatorcontrib>Sharifi, Davood</creatorcontrib><creatorcontrib>Farzan, Arash</creatorcontrib><creatorcontrib>Ghasemi, Setareh</creatorcontrib><creatorcontrib>AliMohammad Kalhori, Katayoun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of photochemistry and photobiology. B, Biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pedram, Mir Sepehr</au><au>Dehghan, Mohammad Mehdi</au><au>Shojaee, Maryam</au><au>Fekrazad, Reza</au><au>Sharifi, Davood</au><au>Farzan, Arash</au><au>Ghasemi, Setareh</au><au>AliMohammad Kalhori, Katayoun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model</atitle><jtitle>Journal of photochemistry and photobiology. B, Biology</jtitle><addtitle>J Photochem Photobiol B</addtitle><date>2018-12</date><risdate>2018</risdate><volume>189</volume><spage>49</spage><epage>54</epage><pages>49-54</pages><issn>1011-1344</issn><eissn>1873-2682</eissn><abstract>Application of Photobiomodulation therapy (PBMT) and meloxicam in acute spinal cord injury, functional recovery and histological evaluation. Evaluation of the effect of simultaneous PBMT and meloxicam on treatment of acute experimental spinal cord injury and comparing it with the effect of application of each of them separately. The study was conducted at the Department of Surgery &amp; Radiology, Faculty of Veterinary Medicine and Institute of Biomedical Research, University of Tehran, Tehran, Iran. Twenty four rats were used in this study. A compression injury was induced to the T8-T9 segment of the spinal cord of rats using a Fogarty embolectomy catheter. Rats were randomly divided into 4 groups including: Control group, PBMT (810 nm-200 mw-8 s-2 weeks) group, Meloxicam (1 mg/kg) group, and PBMT and Meloxicam (mixed) group. After inducing injury, hind limb performance of the rats was evaluated, using BBB test and then treatment intervention was performed and continued for 2 weeks. Four  weeks after injury induction, BBB test results were significantly higher in all treatment groups in comparison to control group, however, there were no significant differences among the treatment groups. In addition, histological findings revealed no significant difference between all 4 study groups. According to the results of this study we can conclude that simultaneous and separate application of PBMT and Meloxicam play an effective role in treatment of acute spinal cord injuries. •Administration of meloxicam can improve clinical features after spinal cord injury.•Using PBMT can improve functional activity of rats suffered from SCI.•Simultaneous application of PBMT and Meloxicam play effective role in treatment of SCI</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>30312920</pmid><doi>10.1016/j.jphotobiol.2018.09.022</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8825-9070</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1011-1344
ispartof Journal of photochemistry and photobiology. B, Biology, 2018-12, Vol.189, p.49-54
issn 1011-1344
1873-2682
language eng
recordid cdi_proquest_miscellaneous_2119930015
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
BBB test
Combined Modality Therapy - methods
Compression
Effects
Evaluation
Experiments
Injuries
Light therapy
Low-Level Light Therapy - methods
Medical instruments
Meloxicam
Meloxicam - therapeutic use
NSAIDs
Photobiomodulation therapy (PBMT)
Radiology
Rats
Recovery of function
Rodents
Spinal cord injuries
Spinal Cord Injuries - therapy
Spinal cord injury
Surgery
Therapy
Treatment Outcome
Veterinary
Veterinary medicine
title Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20effects%20of%20simultaneous%20Photobiomodulation%20therapy%20(PBMT)%20and%20Meloxicam%20administration%20on%20experimental%20acute%20spinal%20cord%20injury:%20Rat%20animal%20model&rft.jtitle=Journal%20of%20photochemistry%20and%20photobiology.%20B,%20Biology&rft.au=Pedram,%20Mir%20Sepehr&rft.date=2018-12&rft.volume=189&rft.spage=49&rft.epage=54&rft.pages=49-54&rft.issn=1011-1344&rft.eissn=1873-2682&rft_id=info:doi/10.1016/j.jphotobiol.2018.09.022&rft_dat=%3Cproquest_cross%3E2119930015%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2164525098&rft_id=info:pmid/30312920&rft_els_id=S1011134418305712&rfr_iscdi=true